Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
08049
Company Profile
Business description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a pharmaceutical company. It is engaged in the manufacturing and distribution of Chinese medicines and pharmaceutical products. The company sells medicines under the brand names: Changlong and Qing Tong. The group has only one business segment which is the manufacture and distribution of Chinese medicines. It derives revenue from operations in the PRC.
Contact
625 & 639 Nathan Road
Room 1101-2, 11th Floor
Office Tower Two, Grand Plaza
Mong kok, Kowloon
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
798
Stocks News & Analysis
stocks
Chart of the Week: AI proving a threat to company moats
The latest insights on AI from our equity research team.
stocks
ASX coal miners will benefit from higher prices
Middle East conflict pushes coal prices higher.
stocks
Nvidia earnings: Another stellar quarter with no signs of a slowdown
We think Nvidia stock is moderately undervalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,705.40 | 6.40 | -0.07% |
| CAC 40 | 7,969.88 | 4.61 | -0.06% |
| DAX 40 | 23,502.25 | 228.67 | -0.96% |
| Dow JONES (US) | 46,225.15 | 768.11 | -1.63% |
| FTSE 100 | 10,305.29 | 98.31 | -0.94% |
| HKSE | 25,645.86 | 379.56 | -1.46% |
| NASDAQ | 22,152.42 | 327.11 | -1.46% |
| Nikkei 225 | 53,787.18 | 1,452.22 | -2.63% |
| NZX 50 Index | 13,042.24 | 273.36 | -2.05% |
| S&P 500 | 6,624.70 | 91.39 | -1.36% |
| S&P/ASX 200 | 8,509.70 | 4.30 | 0.05% |
| SSE Composite Index | 4,031.06 | 31.92 | -0.79% |